Cargando…

Myeloperoxidase and its negative relationship with cholesterol efflux capacity in patients with psoriasis: results from an observational cohort study

Detalles Bibliográficos
Autores principales:	Florida, Elizabeth M., Li, Haiou, Rodante, J., Teague, H. L., Playford, Martin P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589920/ https://www.ncbi.nlm.nih.gov/pubmed/37864160 http://dx.doi.org/10.1186/s12967-023-04506-8

Ejemplares similares

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
por: Berg, Alexander R., et al.
Publicado: (2023)

Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study
por: Sorokin, Alexander V., et al.
Publicado: (2023)

The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2018)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

Abdominal subcutaneous adipose tissue negatively associates with subclinical coronary artery disease in men with psoriasis
por: Teklu, Meron, et al.
Publicado: (2021)

Development and validation of novel automatable assay for cholesterol efflux capacity
por: Mutsuda, Yume, et al.
Publicado: (2023)

Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice
por: Neu, Savannah D., et al.
Publicado: (2021)

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018)

Lower than average HDL cholesterol efflux capacity in Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2019)

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
por: Metzinger, Mark P., et al.
Publicado: (2020)

Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
por: Kingwell, Bronwyn A., et al.
Publicado: (2022)

Targeted cholesterol efflux
por: Fang, Longhou, et al.
Publicado: (2013)

Longitudinal association of epicardial and thoracic adipose tissues with coronary and cardiac characteristics in psoriasis
por: O'Hagan, Ross, et al.
Publicado: (2023)

Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis
por: Gall, Julie, et al.
Publicado: (2016)

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2017)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy
por: Kockx, Maaike, et al.
Publicado: (2022)

Correction to: Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
Publicado: (2023)

Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis
por: Dilek, Nursel, et al.
Publicado: (2016)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL
por: Franssen, Remco, et al.
Publicado: (2012)

Cholesterol efflux capacity assay using immobilized liposomes and apolipoprotein B-depleted serum
por: Sapa, Hima Rani
Publicado: (2019)

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure
por: Bigazzi, Federico, et al.
Publicado: (2017)

Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
por: Ritsch, Andreas, et al.
Publicado: (2020)

A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
por: Xie, Binbin, et al.
Publicado: (2021)

The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation
por: Minami-Takano, Asuka, et al.
Publicado: (2021)

Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Yanagi, Yasuo, et al.
Publicado: (2022)

Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19
por: Stadler, Julia T., et al.
Publicado: (2022)

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
por: Hokstad, Ingrid, et al.
Publicado: (2022)

Additive Effects of Drinking Habits and a Susceptible Genetic Polymorphism on Cholesterol Efflux Capacity
por: Matsumoto, Erika, et al.
Publicado: (2023)

Metabolomic Profiling of Cholesterol Efflux Capacity in a Multiethnic Population: Insights From MESA
por: Hunter, Wynn G., et al.
Publicado: (2023)

HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma
por: Adorni, Maria Pia, et al.
Publicado: (2022)

Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity
por: Koekemoer, Andrea L., et al.
Publicado: (2017)

Effect of Selective Androgen Receptor Modulator on Cholesterol Efflux Capacity, Size, and Subspecies of HDL Particles
por: Guo, Wen, et al.
Publicado: (2022)

Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke
por: Jin, Aoming, et al.
Publicado: (2022)

Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case–control study
por: Sanz, Juana Maria, et al.
Publicado: (2023)

A commentary on the paper, ‘Development and validation of a novel automatable assay for cholesterol efflux capacity’
por: Bhale, Aishwarya Sudam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t389aptvb7k1n1uiqe5tfiliui